Who are placebo + ethinylestradiol/levonorgestrel's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): ethinyl estradiol/etonogestrel vaginal ring, ETHINYL ESTRADIOL AND LEVOGESTREL, Ethinyl Estradiol / Norgestimate Oral Tablet, Estradiol valerate / dienogest, Ethinylestradiol / Norethisterone, OCR.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/placebo-ethinylestradiol-levonorgestrel.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

placebo + ethinylestradiol/levonorgestrel — Competitive Intelligence Brief

placebo + ethinylestradiol/levonorgestrel (placebo + ethinylestradiol/levonorgestrel) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Combined oral contraceptive. Area: Contraception / Reproductive Health.

marketed Combined oral contraceptive Estrogen receptor and progesterone receptor Contraception / Reproductive Health Small molecule Live · refreshed every 30 min

Target snapshot

placebo + ethinylestradiol/levonorgestrel (placebo + ethinylestradiol/levonorgestrel) — HRA Pharma. Ethinylestradiol and levonorgestrel work together as a combined oral contraceptive to prevent ovulation and thicken cervical mucus, thereby preventing pregnancy.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
placebo + ethinylestradiol/levonorgestrel TARGET	placebo + ethinylestradiol/levonorgestrel	HRA Pharma	marketed	Combined oral contraceptive	Estrogen receptor and progesterone receptor
ethinyl estradiol/etonogestrel vaginal ring	ethinyl estradiol/etonogestrel vaginal ring	University of Pittsburgh	marketed	Combined hormonal contraceptive	Estrogen receptor and progesterone receptor
ETHINYL ESTRADIOL AND LEVOGESTREL	ETHINYL ESTRADIOL AND LEVOGESTREL	FHI 360	marketed	Combined oral contraceptive	Estrogen receptor and progesterone receptor
Ethinyl Estradiol / Norgestimate Oral Tablet	Ethinyl Estradiol / Norgestimate Oral Tablet	University of Colorado, Denver	marketed	Oral contraceptive (combined estrogen-progestin)	Estrogen receptor and progesterone receptor
Estradiol valerate / dienogest	Estradiol valerate / dienogest	Helsinki University Central Hospital	marketed	Oral contraceptive (combined estrogen-progestin)	Estrogen receptor and progesterone receptor
Ethinylestradiol / Norethisterone	Ethinylestradiol / Norethisterone	University of Edinburgh	marketed	Combined oral contraceptive	Estrogen receptor and progesterone receptor
OCR	OCR	Hoffmann-La Roche	marketed	Combined oral contraceptive	Estrogen receptor and progesterone receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Combined oral contraceptive class)

University of Palermo · 3 drugs in this class
Teva Branded Pharmaceutical Products R&D, Inc. · 2 drugs in this class
Organon and Co · 2 drugs in this class
HRA Pharma · 1 drug in this class
Hansoh BioMedical R&D Company · 1 drug in this class
Helsinki University Central Hospital · 1 drug in this class
Hoffmann-La Roche · 1 drug in this class
IVI Madrid · 1 drug in this class
Leiden University Medical Center · 1 drug in this class
Massachusetts General Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). placebo + ethinylestradiol/levonorgestrel — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-ethinylestradiol-levonorgestrel. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab